Community spirit in action
What began in 2006 as an ambitious vision to improve community wellbeing in the Illawarra-Shoalhaven, has today grown into a world-class Medical Research Institute (MRI) with over 140 affiliated researchers, as well as their teams of Research Fellows, PhD candidates and higher degree research students.
Our researchers, operations team and founding partners, the University of Wollongong (UOW) and the Illawarra Shoalhaven Local Health District (ISLHD), work together to better understand the causes of disease and illness.
Our goal is to discover more effective ways to prevent and treat cancer, dementia, mental illness and diabetes. These are some of the most common areas of disease and illness that affect our community. Our vision is to improve the health and wellbeing of people living in the Illawarra and Shoalhaven.
Our founding partners and key stakeholders, the University of Wollongong (UOW) and the South Eastern Sydney Illawarra Area Health Service (SESIAHS) sign a memorandum of understanding to foster and expand health and medical research in the Illawarra.
IHMRI was formally constituted as a company limited by guarantee, with the UOW and SESIAHS as its founding members. In 2011 the SESIAHS became the Illawarra Shoalhaven Local Health District (ISLHD).
Professor Don Iverson appointed as IHMRI’s inaugural Executive Director and Sue Baker-Finch appointed as Chief Operating Officer.
A contribution of $15 million from the NSW Government was matched by $15 million from the UOW to allow construction of a headquarters for IHMRI, with world-class research laboratories and clinical trial research facilities.
IHMRI’s state-of-the-art headquarters were completed and officially opened in July by the then NSW Deputy Premier, the Hon Carmel Tebbutt.
IHMRI recognised by the NSW State Government as an independent Medical Research Institute (MRI), allowing access to funding from the NSW Government’s Medical Research Support Program (MRSP).
Professor David J. Adams is appointed as IHMRI’s Chief Executive Officer / Executive Director in December.
Professor Leonard Arnold is appointed as Clinical Director, a new role shared between IHMRI and ISLHD to encourage and support clinical research in the region and facilitate collaborations between IHMRI-affiliated academic and clinician researchers.
Kara Lamond appointed as Chief Operating Officer in August.
IHMRI opens a second Clinical Research and Trials Unit (CRTU) in Lawson House at Wollongong Hospital, providing clinician researchers with a dedicated space to conduct research with their patients.